Cipla secures exclusive rights to market Formosa Pharmaceuticals’ APP13007 across 11 countries

Cipla Limited has expanded its presence in the ophthalmology market through a multi-regional licensing agreement with Formosa Pharmaceuticals, granting it exclusive rights to commercialize APP13007, ... Read More